PhAST
PhAST Diagnostics develops an AI imaging technology for combating antibiotic resistance. Its cloud-based platform provides clinical decision support for doctors, workflow improvement for hospitals, and helps accelerate the drug development process for pharmaceutical companies.
Funding
Every round, secondary, debt facility or acquisition involving PhAST that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in